Colony stimulating factor 1 receptor

Colony stimulating factor 1 receptor (CSF1R) is a protein that in humans is encoded by the CSF1R gene. This receptor is a member of the tyrosine kinase family of receptors and plays a crucial role in the regulation of macrophage production, differentiation, and function.
Structure[edit]
CSF1R is a transmembrane protein that consists of an extracellular domain, a single transmembrane helix, and an intracellular tyrosine kinase domain. The extracellular domain is responsible for binding to its ligand, colony stimulating factor 1 (CSF1), and interleukin-34 (IL-34).
Function[edit]
CSF1R is primarily expressed on the surface of macrophages and their precursors. Upon binding to its ligands, CSF1R undergoes dimerization and autophosphorylation, which activates its intrinsic tyrosine kinase activity. This activation triggers a cascade of downstream signaling pathways that promote the survival, proliferation, and differentiation of macrophages.
Role in Disease[edit]
Mutations in the CSF1R gene have been associated with several diseases, including hereditary diffuse leukoencephalopathy with spheroids (HDLS), a rare neurodegenerative disorder. Overexpression of CSF1R has also been implicated in certain types of cancer, such as breast cancer and prostate cancer, where it may contribute to tumor growth and metastasis.
Clinical Significance[edit]
CSF1R is a potential therapeutic target for diseases involving macrophage dysregulation. Inhibitors of CSF1R are being investigated for their potential to treat conditions such as rheumatoid arthritis, multiple sclerosis, and certain cancers.
Related Pages[edit]
- Macrophage
- Tyrosine kinase
- Colony stimulating factor 1
- Interleukin-34
- Hereditary diffuse leukoencephalopathy with spheroids
- Breast cancer
- Prostate cancer
- Rheumatoid arthritis
- Multiple sclerosis
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian